AEYE Diagnostic Screening (AEYE-DS)
Autonomous Screening for
Diabetic Retinopathy (DR)
The first practical point-of-care screening solution for diabetic retinopathy
.png)
Compatible Retinal Cameras
Cost-effective, portable retinal camera with built-in diagnostic screening intelligence
Portable camera enabling point of screening, anywhere, whether at home or in-clinic
Internet-connected camera automatically processes exams and provide a diagnostic result on the spot
See the AEYE-DS with Aurora in Action
AEYE with Topcon
Robotic tabletop camera for superior ease of use
_edited.png)
Robotic camera automatically captures images
AI diagnoses images on the spot, with no need for a specialist over read
See the AEYE-DS with Topcon in Action
Advantages of AEYE-DS
Accessible
Enables point of care screenings anywhere, whether at home or in-clinic
_edited.png)
1-minute Screening
Requires only one image per eye; rarely requires dilation; producing instant diagnosis
Benefits of Point-of-Care Screening
_edited.png)
Reimbursable
Dedicated CPT code 92229 for AI diabetic retinopathy screening
Closes Care Gaps
Closes the care diabetic eye gap, improving HEDIS scores and and Star ratings
Indications for Use
The AEYE-DS is indicated for use by health care providers to automatically detect more than mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy. AEYE-DS is indicated for use with the Topcon NW400 camera and the Optomed Aurora camera.
Accuracy & Usability
In an FDA clinical study assessing the detection of more-than-mild diabetic retinopathy, the AEYE-DS exhibited sensitivity range of 92%-93% and specificity range of 89%-94% when utilizing a single image per eye with the Optomed Aurora camera, and 93% sensitivity and over 91% specificity using one image per eye captured using the Topcon NW400.
